T cell response to amyloid-β and to mitochondrial antigens in Alzheimer's disease

被引:25
|
作者
Giubilei, F [1 ]
Antonini, G [1 ]
Montesperelli, C [1 ]
Sepe-Monti, M [1 ]
Cannoni, S [1 ]
Pichi, A [1 ]
Tisei, P [1 ]
Casini, AR [1 ]
Buttinelli, C [1 ]
Prencipe, M [1 ]
Salvetti, M [1 ]
Ristori, G [1 ]
机构
[1] Univ Roma La Sapienza, Dipartimento Sci Neurol, I-00185 Rome, Italy
关键词
Alzheimer's disease; amyloid-beta; T lymphocytes; T cell reactivity; mitochondrial antigens;
D O I
10.1159/000069991
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Despite the vast amount of literature on non-specific immune mechanisms in Alzheimer's disease (AD), little is known about the role of antigen-specific immune responses. We investigated T cell reactivity to fragment 1-42 of amyloid-beta (Abeta) and to N-terminal peptides of human mitochondrial and control microbial proteins. Thirty subjects with a diagnosis of probable AD according to NINCDS-ADRDA criteria and 30 sex- and age-matched healthy controls were enrolled. T cell responses to Abeta fragment showed no significant differences between AD patients and controls. By contrast, the mean number of positive T cell responses to both human mitochondrial and microbial peptides was significantly decreased in AD patients compared to control subjects. No significant correlation was found between T cell responses and both the severity of cognitive impairment and duration of the disease. Our results suggest that antigen-specific immune responses are impaired in AD. Protective immune responses to harmful amyloidogenic substances may also be impaired, thus favoring their accumulation in the brain. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 50 条
  • [21] Metabolism of amyloid-β peptide and Alzheimer's disease
    Iwata, N
    Higuchi, M
    Saido, TC
    PHARMACOLOGY & THERAPEUTICS, 2005, 108 (02) : 129 - 148
  • [22] Alzheimer's disease: the ins and outs of amyloid-β
    Beyreuther, Konrad
    Masters, Colin L.
    Nature, 1997, 389 (6652):
  • [23] Aluminum and Amyloid-β in Familial Alzheimer's Disease
    Mold, Matthew
    Linhart, Caroline
    Gomez-Ramirez, Johana
    Villegas-Lanau, Andres
    Exley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 73 (04) : 1627 - 1635
  • [24] Amyloid-β: A double agent in Alzheimer's disease?
    Yu, Hao
    Wu, Jie
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [25] Citrullination of Amyloid-β Peptides in Alzheimer's Disease
    Mukherjee, Soumya
    Perez, Keyla A.
    Dubois, Celine
    Nisbet, Rebecca M.
    Li, Qiao-Xin
    Varghese, Shiji
    Jin, Liang
    Birchall, Ian
    Streltsov, Victor A.
    Vella, Laura J.
    McLean, Catriona
    Barham, Kevin J.
    Roberts, Blaine R.
    Masters, Colin L.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (19): : 3719 - 3732
  • [26] Synaptic activity, amyloid-β and Alzheimer's disease
    Cirrito, John R.
    Holtzman, David M.
    ALZHEIMER: 100 YEARS AND BEYOND, 2006, : 209 - +
  • [27] Amyloid-β-directed immunotherapy for Alzheimer's disease
    Lannfelt, L.
    Relkin, N. R.
    Siemers, E. R.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (03) : 284 - 295
  • [28] Cell degeneration induced by amyloid-β peptides -: Implications for Alzheimer's disease
    Pereira, C
    Ferreiro, E
    Cardoso, SM
    de Oliveira, CR
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (1-2) : 97 - 104
  • [29] Amyloid-β and Glucose Metabolism in Alzheimer's Disease
    Furst, Ansgar J.
    Lal, Rayhan A.
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 : 105 - 116
  • [30] Synaptic Retrogenesis and Amyloid-β in Alzheimer's Disease
    Wasling, Pontus
    Daborg, Jonny
    Riebe, Ilse
    Andersson, My
    Portelius, Erik
    Blennow, Kaj
    Hanse, Eric
    Zetterberg, Henrik
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (01) : 1 - 14